
David Prosser
Freelance Journalist at Freelance
Freelance journalist and consultant, and a former business editor of The Independent
Articles
-
4 days ago |
forbes.com | David Prosser
Chronicle co-founders Mayuresh Patole and Tejas GawandeChronicleFounders sometimes make it sound as if starting a business is easy. There are endless stories about entrepreneurs who had a moment of inspiration, raised plenty of capital and built valuable businesses, seemingly in a flash. But what about all the founders who spend years struggling to turn their visions into reality?
-
5 days ago |
forbes.com | David Prosser
In a world where innovation and technology are transforming the way in which enterprises work, it sometimes feels as if operational assets such as warehouses are behind the pace. Many large manufacturing businesses and logistics operators still run noisy and dirty facilities that rely on large numbers of staff working through manual processes.
-
5 days ago |
moneyweek.com | David Prosser
Would you spend millions of pounds on a property on the other side of the world that you may not even have seen in person? A growing number of investors are doing exactly that. The international market for luxury property is well established, but in recent years, the number of such homes sold at auction, often to overseas buyers who haven’t conducted a viewing, has increased rapidly.
-
1 week ago |
forbes.com | David Prosser
Which market is growing even more quickly than artificial intelligence (AI) technology right now? It’s a trick question – the answer is the market for products and services that keep AI technologies honest. The global AI governance industry was worth $890 million last year according to a recent study from Markets & Markets; by 2029, it will be worth $5.8 billion, the market research group reckons. That represents annual growth of a little over 45%. It's not difficult to see why.
-
1 week ago |
forbes.com | David Prosser
Adverse reactions are a hugely challenging problem for drug developers and biotech companies. A drug that has the potential to help patients with very serious conditions – cancers and auto-immune diseases, for example – proves ineffective because the human immune system identifies it as a foreign body and attacks it. Sometimes this happens with all patients; in other cases, the response is individual.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 3K
- Tweets
- 356
- DMs Open
- No

RT @DavenantFS: A Blast from the past… were you a student or a teacher at Davenant? This Friday we are launching ‘The 1680s’ which is our n…

RT @sageuk: The #SageDownload has hit 50,000 subscribers 🥳 Huge thanks to our contributors and to everyone who has subscribed so far! Li…

RT @sageireland: The #SageDownload has hit 50,000 subscribers 🥳 Huge thanks to our contributors and to everyone who has subscribed so far!…